Zou, Jing
Xia, Hongjie http://orcid.org/0000-0002-2520-7038
Xie, Xuping http://orcid.org/0000-0003-0918-016X
Kurhade, Chaitanya
Machado, Rafael R. G.
Weaver, Scott C. http://orcid.org/0000-0001-8016-8556
Ren, Ping http://orcid.org/0000-0002-4022-6667
Shi, Pei-Yong http://orcid.org/0000-0001-5553-1616
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | Center for Information Technology (HHSN272201600013C, AI134907, AI145617, UL1TR001439)
Article History
Received: 21 December 2021
Accepted: 2 February 2022
First Online: 9 February 2022
Competing interests
: The authors declare competing interests. X.X. and P.-Y.S. have filed a patent on the reverse genetic system. J.Z., H.X., X.X., and P.-Y.S. received compensation from Pfizer for COVID-19 vaccine development. Other authors declare no competing interests.